Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
Status:
Completed
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
This study is a randomized controlled trial (RCT) to compare the effects of varenicline,
cytisine, and nicotine replacement therapy (NRT) to reduce: 1) alcohol use and craving, 2)
smoking; and 3) inflammation and risk for coronary heart disease (CHD) and mortality among
400 HIV-infected Russians, with heavy alcohol consumption and tobacco use.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Boston Medical Center
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)